Showing results 1 to 7 of 7
Issue Date | Title | Author(s) |
---|---|---|
2023-01 | Combination treatment of hepatitis C virus-associated hepatocellular carcinoma by simultaneously blocking genes in multiple organelles via functionally engineered graphene oxide | Kim, Seongchan; Lee, Ji-Seon; 이효진 |
2009-09-30 | Decreased Expression of the Suppressor of Cytokine Signaling 6 in Human Hepatocellular Carcinoma | Bae, Hyun Jin; Noh, Ji Heon; Eun, Jung Woo; Kim, Jeong Kyu; Jung, Kwang Hwa; Xie, Hong Jian; Ahn, Young Min; Ryu, Jae Chun; Park, Won Sang; Lee, Jung Young; Nam, Suk Woo |
2020-08 | Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma | Ko, Hyeonseok; Huh, Gyuwon; Jung, Sang Hoon; Kwon, Hyukjoon; Jeon, Youngsic; Park, Young Nyun; Kim, Young-Joo |
2022-11 | DN200434, an orally available inverse agonist of estrogen-related receptor gamma, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma | Kim, Dong-Ho; Kim, Mi-Jin; Kim, Na-Young; Lee, Seunghyeong; Byun, Jun-Kyu; Yun, Jae Won; Lee, Jaebon; Jin, Jonghwa; Kim, Jina; Chin, Jungwook; Cho, Sung Jin; Lee, In-Kyu; Choi, Yeon-Kyung; Park, Keun-Gyu |
2019-11-14 | MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes | Elemeery, Moustafa Nouh; Mohamed, Marwa Anwar; Madkour, Marwa Ahmed; Shamseya, Mohammed Mohammed; Issa, Noha Mahmoud; Badr, Ahmed Noah; Ghareeb, Doaa Ahmed; Pan, Cheol-Ho |
2021-05 | Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector | Lee, Sungjin; Kim, Young-Youb; Ahn, Hyung Jun |
2009-11 | The Antitumor Effect and Hepatotoxicity of a Hexokinase II Inhibitor 3-Bromopyruvate: In Vivo Investigation of Intraarterial Administration in a Rabbit VX2 Hepatoma Model | Jae, Hwan Jun; Chung, Jin Wook; Park, Hee Sun; Lee, Min Jong; Lee, Ki Chang; Kim, Hyo-Cheol; Yoon, Jung Hwan; Chung, Hesson; Park, Jae Hyung |